文献速递主动脉外科

顺行胸主动脉腔内修复术治疗胸主动脉疾病的多中心经验

Multicentre experience of antegrade thoracic endovascular aortic repair for the treatment of thoracic aortic diseases.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

该多中心回顾性队列研究纳入2010年1月至2021年12月接受顺行TEVAR的14例患者,技术成功率达100%,但早期死亡4例(28%)均为急诊手术,晚期I型内漏及主动脉相关再干预率较高。作者认为顺行TEVAR仅在传统逆行途径不可行时可作为替代选择。

要点

  • 14例顺行TEVAR技术成功率为100%,早期死亡4例(28%)均为急诊手术。
  • 择期手术患者12、24、36个月生存率分别为100%、84%、67%。
  • 免于再干预率12、24、36个月分别为92%、56%、56%。

核心结论

  • 顺行TEVAR仅在传统逆行途径不可行时可作为替代选择,尽管技术成功率高且入路部位并发症少,但晚期I型内漏和主动脉相关再干预率较高。

研究设计与样本

  • 多中心回顾性队列研究,纳入2010年1月至2021年12月期间接受顺行TEVAR的14例患者,包括择期和急诊手术,排除既往或同期外科或血管内修复中部署的覆膜支架。

主要发现

  • 14例患者中13例(94%)为男性,平均年龄71岁(四分位距62;78)。
  • 5例(36%)接受急诊手术(2例主动脉破裂,3例有症状)。
  • 适应证为动脉瘤/假性动脉瘤8例(57%)、夹层3例(21%)、穿透性主动脉溃疡3例(21%)。
  • 所有手术技术成功;早期死亡4例(28%),均为急诊手术。
  • 中位随访13个月(四分位距1;44),晚期死亡2例(20%),均为择期手术患者;1例在19个月时死于主动脉相关再干预,另1例在34个月时死于非主动脉相关原因。

临床怎么用

  • 作者认为顺行TEVAR仅在传统逆行途径不可行时可考虑作为替代选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The goal of this multicentre retrospective cohort study was to evaluate technical success and early and late outcomes of thoracic endovascular repair (TEVAR) with grafts deployed upside down through antegrade access, to treat thoracic aortic diseases. METHODS: Antegrade TEVAR operations performed between January 2010 and December 2021 were collected and analysed. Both elective and urgent procedures were included. Exclusion criteria were endografts deployed in previous or concomitant surgical or endovascular repairs. RESULTS: Fourteen patients were enrolled; 13 were males (94%) with a mean age of 71 years (interquartile range 62; 78). Five patients underwent urgent procedures (2 ruptured aortas and 3 symptomatic patients). Indications for treatment were 8 (57%) aneurysms/pseudoaneurysms, 3 (21%) dissections and 3 (21%) penetrating aortic ulcers. Technical success was achieved in all procedures. Early mortality occurred in 4 (28%) cases, all urgent procedures. Median follow-up was 13 months (interquartile range 1; 44). Late deaths occurred in 2 (20%) patients, both operated on in elective settings. The first died at 19 months of aortic-related reintervention; the second died at 34 months of a non-aortic-related cause. Two patients (14%) underwent aortic-related reinterventions for late type I endoleak. The survival rate of those having the elective procedures was 100%, 84% and 67% at 12, 24 and 36 months, respectively. Freedom from reintervention was 92%, 56% and 56% at 12, 24 and 36 months, respectively. CONCLUSIONS: Antegrade TEVAR can seldom be considered an alternative when traditional retrograde approach is not feasible. Despite good technical success and few access-site complications, this study demonstrates high rates of late type I endoleak and aortic-related reinterventions.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Gibello L, Antonello M, Civilini E, et al. Multicentre experience of antegrade thoracic endovascular aortic repair for the treatment of thoracic aortic diseases. Eur J Cardiothorac Surg. 2024. PMID: 38733578. doi:10.1093/ejcts/ezae185

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。